These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 316034)
1. [Exocrine pancreatic function test by a synthetic peptide in pancreatic and hepatobiliary diseases: in comparison with pancreozymin secretin test (author's transl)]. Ikubo I; Harada H; Shundo T; Takeda M; Yabe H; Hanafusa E; Kimura I Nihon Shokakibyo Gakkai Zasshi; 1979 Sep; 76(9):1842-50. PubMed ID: 316034 [No Abstract] [Full Text] [Related]
3. Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Lankisch PG; Brauneis J; Otto J; Göke B Gastroenterology; 1986 Feb; 90(2):350-4. PubMed ID: 3484456 [TBL] [Abstract][Full Text] [Related]
4. Preliminary evaluation of a single-day tubeless test of pancreatic function. Mitchell CJ; Field HP; Simpson FG; Parkin A; Kelleher J; Losowsky MS Br Med J (Clin Res Ed); 1981 May; 282(6278):1751-3. PubMed ID: 6786606 [TBL] [Abstract][Full Text] [Related]
5. [A new test of exocrine pancreatic function using N-benzoyl-L-tyrosyl-p-aminobenzoic acid. Part II. The correlation of PFD and chymotrypsin output during PS-test (author's transl)]. Kinugasa K Nihon Shokakibyo Gakkai Zasshi; 1977 Oct; 74(10):1337-46. PubMed ID: 304114 [No Abstract] [Full Text] [Related]
6. [Oral administration of a chymotrypsin-labile synthetic peptide, a new test for exocrine pancreatic function, and its diagnostic value in pancreatic diseases (author's transl)]. Takayama T; Hayakawa T; Noda A; Aoki I; Horiguchi Y; Yamazaki Y; Ito K; Naruse S; Kondo T; Iinuma Y Nihon Naika Gakkai Zasshi; 1980 Apr; 69(4):447-53. PubMed ID: 6967099 [No Abstract] [Full Text] [Related]
7. [Clinical studies on the exocrine pancreatic function test by oral administration of N-benzoyl-L-tyrosyl-PABA combined with the PABA absorption test (author's transl)]. Kimura T; Wakasugi H; Funakoshi A; Matsumoto M; Ibayashi H Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):259-65. PubMed ID: 312346 [No Abstract] [Full Text] [Related]
8. Diagnostic tests of exocrine pancreatic function and disease. Arvanitakis C; Cooke AR Gastroenterology; 1978 May; 74(5 Pt 1):932-48. PubMed ID: 76589 [No Abstract] [Full Text] [Related]
9. Evaluation of postoperative exocrine pancreatic function using chymotrypsin labile peptide. Manabe T; Yokota T; Tobe T Jpn J Surg; 1982; 12(3):178-83. PubMed ID: 6982366 [TBL] [Abstract][Full Text] [Related]
10. [Studies on pancreozymin-secretin test. Clinical significance of pancreozymin-secretin test in liver and biliary diseases (author's transl)]. Watanabe S Nihon Naika Gakkai Zasshi; 1973 Oct; 62(10):1352-65. PubMed ID: 4797509 [No Abstract] [Full Text] [Related]
11. [Clinical significance of PFD test and fecal chymotrypsin test in postoperative pancreatic exocrine insufficiency]. Yagi M; Onoda H; Takamori M; Watanabe T; Konishi K; Nagakawa T; Miwa K; Miyazaki I Nihon Shokakibyo Gakkai Zasshi; 1988 Jun; 85(6):1282-7. PubMed ID: 3265737 [No Abstract] [Full Text] [Related]
12. The bentiromide test: how good is it? Heyman MB Gastroenterology; 1985 Sep; 89(3):685-7. PubMed ID: 3874805 [No Abstract] [Full Text] [Related]
13. Prospective comparison of three non-invasive tests for pancreatic disease. Braganza J Br Med J (Clin Res Ed); 1984 Sep; 289(6444):562. PubMed ID: 6432191 [No Abstract] [Full Text] [Related]
14. [Increased diagnostic value of PFD by oral administration of PABA (PABA absorption test) (author's transl)]. Inada Y; Kashima K; Kinugasa K; Horii Y; Morinaga O; Takino T Nihon Shokakibyo Gakkai Zasshi; 1981 Jan; 78(1):71-80. PubMed ID: 6973654 [No Abstract] [Full Text] [Related]
15. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome. Weizman Z; Forstner GG; Gaskin KJ; Kopelman H; Wong S; Durie PR Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804 [TBL] [Abstract][Full Text] [Related]
16. [Direct determination of the secretory capacity of the pancreas after hormonal stimulation. 3. Diagnostic value of the secretin and pancreozymin-secretin test]. Herfort K; Fric P; Bartos V Cas Lek Cesk; 1968 Aug; 107(34):1062-8. PubMed ID: 5680627 [No Abstract] [Full Text] [Related]
17. Evaluation of a single-day tubeless test of pancreatic function. Kay G; Tetlow VA; Lobley RW; Braganza J; Herman K Br Med J (Clin Res Ed); 1981 Aug; 283(6287):382. PubMed ID: 6788338 [No Abstract] [Full Text] [Related]
18. [The oral administration of N-benzoyl-L-tyrosyl-paraaminobenzoic acid (PFT) in the assessment of exocrine pancreatic function and its value within the diagnostic approach to pancreatic disease (author's transl)]. Fettes F; Gyr K; Singeisen M; Kayasseh L; Stalder GA Z Gastroenterol; 1978 Mar; 16(3):141-8. PubMed ID: 305693 [TBL] [Abstract][Full Text] [Related]
19. Reliability of the Bz-Ty-PABA and the pancreolauryl test in the assessment of exocrine pancreatic function. Cavallini G; Piubello W; Brocco G; Vantini I; Angelini G; Benini L; Chech G; Marchiaro G; Dobrilla G; Bonoldi C Digestion; 1983; 27(3):129-37. PubMed ID: 6605266 [TBL] [Abstract][Full Text] [Related]
20. Prospective comparison of three non-invasive tests for pancreatic disease. Cobden I; Lendrum R; James OF; Venables CW; Tarbit I; Hawkins T Br Med J (Clin Res Ed); 1984 Sep; 289(6448):830. PubMed ID: 6434101 [No Abstract] [Full Text] [Related] [Next] [New Search]